Psyence Group Inc.
CSE: PSYG
Company Overview
The Psyence network, team and operations are located across Toronto (Canada), Washington DC (United States of America), Cape Town (South Africa), Lesotho (Kingdom of Lesotho), Kingston (Jamaica), London (United Kingdom), Sydney (Australia) and Sao Paulo (Brazil).
The company operates in four division:
- Psyence Therapeutics: Medicinal formulations and therapies to treat mental health disorders in a clinical environment.
- Psyence Production: The first commercially licensed and scalable non-synthetic GMP psilocybin cultivation and processing facility.
- Psyence Experience: Premium retreats in Jamaica and Southern Africa reconnect people to nature, nourishing mind and body, and elevating consciousness.
- Psyence Function: Industry-leading health and wellbeing products that support the Psyence purpose and are based on proprietary formulations.
Financial Highlights
$5,541
Revenue (ttm)
$0
Gross Profit (ttm)
-$0.10
Diluted EPS (ttm)
Management Team
Mr. Jody Aufrichtig
Co-Founder & Exec. Chairman
Dr. Neil Maresky M.D.
CEO & Director
Mr. Alan Mark Friedman B.Com., Bcomm, Bproc Law
Co-Founder & Director
Mr. Warwick Corden-Lloyd
CFO & Corp. Sec.
Dr. Amza Ali M.D.
Director & Chief Medical Officer
Mr. Mike Dacks
Chief Operating Officer
Dr. Justin Grant M.B.A., Ph.D., MBA
Chief Scientific Officer
Ms. Taryn Vos
Gen. Counsel
Ms. Mary-Elizabeth Gifford
Exec. VP of Public Affairs & Corp. Social Responsibility
Dr. Dingle Spence B.Sc., M.D., MBBS
Chief Medical Officer of Psyence Jamaica
Key Highlights
Market Capitalization
$0
Shares Outstanding
0
Shares Short (% of Float)
()
Insider Ownership
4%